Description
Cartalax is a synthetic bioregulatory peptide studied for its influence on fibroblast activity and connective tissue function. Research indicates that Cartalax may support cellular proliferation and modulate the expression of cytokines and signaling molecules linked to cellular senescence. Experimental models have explored its potential effects on skin, kidney, and other connective tissues. Findings suggest Cartalax may promote cellular health by enhancing regeneration pathways and reducing markers of cell death.